A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial
Yoichiro Yoshida,1 Keiji Hirata,2 Hiroshi Matsuoka,3 Shigeyoshi Iwamoto,4 Masahito Kotaka,5 Hideto Fujita,6 Naoya Aisu,1 Seiichiro Hoshino,1 Takeo Kosaka,6 Kotaro Maeda,3 Fumiaki Kiyomi,7 Yuichi Yamashita1 1Department of Gastroenterological Surgery, Fukuoka University Faculty of Medicine, Fukuoka, J...
Saved in:
Main Authors: | Yoshida Y (Author), Hirata K (Author), Matsuoka H (Author), Iwamoto S (Author), Kotaka M (Author), Fujita H (Author), Aisu N (Author), Hoshino S (Author), Kosaka T (Author), Maeda K (Author), Kiyomi F (Author), Yamashita Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Characterization of Standard Analgesics on Oxaliplatin-Induced Acute Cold Hypersensitivity in Mice
by: Meng Zhao, et al.
Published: (2014) -
Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice
by: Zhao Meng, et al.
Published: (2012) -
A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation
by: Chen J, et al.
Published: (2015) -
"COVID Arm" in the family medicine setting: Moderna vaccine hypersensitivity reaction
by: Lara L Cohen, et al.
Published: (2022) -
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
by: Chen J, et al.
Published: (2022)